With semaglutide, total alcohol intake decreased by 1,550 g/30 days, compared with an approximate reduction of 1,026 g/30 days in the placebo group (estimated between-group difference of ~468 g/30 days), and the number of drinks per day decreased by 3.5 units
This DIY beauty recipe is perfect for keeping your skin hydrated and glowing
In September 2024, Terns Pharmaceuticals announced positive results from its Phase 1 clinical trial for TERN-601, a once-daily oral GLP-1 receptor agonist aimed at treating obesity
Most GLP-1 probiotics fall into a few broad categories
Novel GLP-1 (Glucagon-like peptide-1) analogues and insulin in the treatment for alzheimers disease and other neurodegenerative diseases
Does glutathione supplement affect fetal development